文献速递肝胆胰外科围术期管理与 ERAS

腹腔镜与开腹肝尾状叶切除术的回顾性对比研究

Laparoscopic versus open surgery for hepatic caudate lobectomy: a retrospective study.
PubMed 文献 · Surg Endosc · 2022-09-22

本研究对比腹腔镜肝尾状叶切除术(LHCL)与开腹肝尾状叶切除术(OHCL)治疗肝肿瘤的可行性与安全性,纳入各24例匹配患者。结果显示LHCL组切口长度和术中出血量显著低于OHCL组,总手术时间、肝门阻断时间及阻断率无显著差异;LHCL组术后48小时严重疼痛比例和地佐辛用量显著降低。

要点

  • LHCL组切口长度和术中出血量显著低于OHCL组。
  • 两组总手术时间、肝门阻断时间和阻断率无显著差异。
  • LHCL组术后48小时严重疼痛比例和地佐辛用量显著降低。

核心结论

  • LHCL治疗肝肿瘤有效且可行,具有减少术中出血和严重疼痛的特点。

研究设计与样本

  • 回顾性研究,LHCL组纳入2014年1月至2019年1月山东大学齐鲁医院24例肝肿瘤患者,另匹配24例OHCL患者作为对照。

主要发现

  • LHCL组切口长度显著低于OHCL组(4.22 ± 1.14 cm vs. 22.46 ± 4.40 cm,P < 0.001)。
  • LHCL组术中出血量显著低于OHCL组(116.82 ± 71.61 ml vs. 371.74 ± 579.35 ml,P = 0.047)。
  • 两组总手术时间、肝门阻断时间及阻断率无统计学差异(P > 0.05)。
  • 两组术后24和48小时VAS评分无统计学差异(P > 0.05)。
  • LHCL组术后48小时严重疼痛比例(0 vs. 4.25 ± 0.46,P < 0.001)和地佐辛用量(90.45 ± 45.77 mg vs. 131.6 ± 81.30 mg,P = 0.0448)显著降低。

临床怎么用

  • 对于合适肝肿瘤患者,LHCL可减少术中出血和术后严重疼痛,且不延长手术时间或增加肝门阻断需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study was designed to investigate the feasibility and safety of laparoscopic hepatic caudate lobectomy (LHCL) for treating liver tumor by comparing with the open hepatic caudate lobectomy (OHCL). METHODS: In the LHCL group, we included 24 patients with liver tumor received LHCL in Qilu Hospital of the Shandong University from January 2014 to January 2019. Meanwhile, 24 matched liver tumor patients underwent OHCL in our hospital served as control. Then we compared the patient characteristics, intraoperative parameters, and postoperative outcomes between LHCL group and OHCL group. RESULTS: There were no significant differences in gender, age, degree of cirrhosis, tumor size, preoperative liver function, Child-Pugh grading, proportion of liver cirrhosis, and tumor size between LHCL group and OHCL group (P > 0.05). No death was reported in both groups. The length of incision in LHCL group was significantly lower than that in OHCL group (4.22 ± 1.14 cm vs. 22.46 ± 4.40 cm, P < 0.001). The intraoperative blood loss in LHCL group was significantly lower than that of OHCL group (116.82 ± 71.61 ml vs. 371.74 ± 579.35 ml, P = 0.047). The total operation time, Pringle maneuver occlusion time, and blocking rate in LHCL group showed no statistical difference compared with those of the OHCL group (P > 0.05). The VAS scores at postoperative 24 and 48 h showed no statistical differences between LHCL group and OHCL group (P > 0.05). Compared with the OHCL group, significant decrease was noticed in the proportion of patients with severe pain 48 h after surgery (0 vs. 4.25 ± 0.46, P < 0.001) and dezocine consumption (90.45 ± 45.77 mg vs. 131.6 ± 81.30 mg, P = 0.0448) in the LHCL group. CONCLUSION: LHCL is effective and feasible for treating liver tumor, which is featured by reducing intraoperative blood loss and serious pain.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Jiang Z, Du G, Wang X, et al. Laparoscopic versus open surgery for hepatic caudate lobectomy: a retrospective study. Surg Endosc. 2022. PMID: 36138251. doi:10.1007/s00464-022-09631-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。